AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Biohit Oyj

Director's Dealing Mar 1, 2017

3304_rns_2017-03-01_45b1d361-f613-4155-ae76-ce2c8cc1e2ee.html

Director's Dealing

Open in Viewer

Opens in native device viewer

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, March 1, 2017 at 12:00 am local time (EET)

Person subject to the notification requirement
Name: Hendolin, Panu
Position: Other senior manager


Initial Notification
Reference number: 74370089ATTSNBXJVT29_20170301090243_16


Issuer
Name: Biohit Oyj
LEI: 74370089ATTSNBXJVT29


Transaction details
Transaction date: 2017-02-24
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Exercise (Rights, Put and Call Options)
Further details:
Linked to stock option programme

Instrument: Financial Instrument Linked to a Share or a Debt
Instrument
ISIN: FI4000219324

Volume: 175
Unit price: 3,40340 Euro

Aggregated transactions
Volume: 175
Volume weighted average price: 3.40340 Euro


Transaction details
Transaction date: 2017-02-27
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Exercise (Rights, Put and Call Options)
Further details:
Linked to stock option programme

Instrument: Financial Instrument Linked to a Share or a Debt
Instrument
ISIN: FI4000219324

Volume: 4589
Unit price: 3,13780 Euro

Aggregated transactions
Volume: 4589
Volume weighted average price: 3.13780 Euro


Transaction details
Transaction date: 2017-02-27
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Subscription
Further details:
Linked to stock option programme

Instrument: Financial Instrument Linked to a Share or a Debt
Instrument
ISIN: FI4000219324

Volume: 2324
Unit price: 2,27660 Euro

Aggregated transactions
Volume: 2324
Volume weighted average price: 2.27660 Euro


Transaction details
Transaction date: 2017-02-27
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Disposal
Further details:
Linked to stock option programme

Instrument: Financial Instrument Linked to a Share or a Debt
Instrument
ISIN: FI4000219324

Volume: 2324
Unit price: 0,00000 Euro

Aggregated transactions
Volume: 2324
Volume weighted average price: 0.00000 Euro


Transaction details
Transaction date: 2017-02-27
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Subscription
Further details:
Linked to stock option programme

Instrument: Financial Instrument Linked to a Share or a Debt
Instrument
ISIN: FI4000219324

Volume: 99
Unit price: 2,27660 Euro

Aggregated transactions
Volume: 99
Volume weighted average price: 2.27660 Euro


Transaction details
Transaction date: 2017-02-27
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Disposal
Further details:
Linked to stock option programme

Instrument: Financial Instrument Linked to a Share or a Debt
Instrument
ISIN: FI4000219324

Volume: 99
Unit price: 0,00000 Euro

Aggregated transactions
Volume: 99
Volume weighted average price: 0.00000 Euro

Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
[email protected]
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B
share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.